Triptorelin
Purrptide digest
Triptorelin is a potent GnRH agonist, FDA-approved for prostate cancer and central precocious puberty, working through the same desensitization mechanism as its peers. In a single dose, it can be used diagnostically to provoke a strong LH/FSH response and assess pituitary function — a sharp, useful clinical tool when used precisely. It's also used off-label by some clinics to help restart natural hormone production after a course of anabolic steroids or TRT, leveraging that same provocative pulse before the suppressive phase kicks in.
What this means for you
If you've heard about this for post-cycle hormone recovery, know that timing and dosing precision matter enormously — this isn't a casual self-experiment.
FDA-approved for prostate cancer and precocious puberty, with off-label use in hormone-recovery protocols leveraging the initial agonist flare before downregulation.
The diagnostic single-dose stimulation test use case is a clean, well-validated application of GnRH agonist pharmacology.
An approved, established drug with a stable indication base. Not a frontier opportunity, but a reliable one.
For the nerds
Effect of testosterone supplementation on functional mobility and hormone levels
Journal of Clinical Endocrinology & Metabolism · DOI: 10.1210/jc.2005-2847
Read full paper on PubMed →